Frontlight ResearchEarly access
Taking peopleNo phase
Feasibility Study of the Tioga TMVR System
Key facts
- Who runs it
- Tioga Cardiovascular, Inc.
- Where
- Brazil, Georgia, Lithuania, and Paraguay5 sites in 4 countriesChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 30 people, planned
- Started
- 1 Apr 2024
- Expected to end
- 1 Jul 2028
- Type of study
- Interventional
- Treatments tested
- Tioga TMVR System
- Record updated
- 12 November 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 33 criteriaShow less
Who can take part
- Age 18 years or older
- Symptomatic, moderate to severe (3+) or severe (4+) MR
- NYHA Functional Classification ≥ II
- Heart team concurs that the subject is non-ideal for surgical intervention or other available treatment options (e.g., TEER)
- The subject or the subject's legal representative has been informed of the nature of the study, has agreed to return for post-procedure follow-up visits, and has provided informed consent
Who cannot take part
- Prior mitral valve intervention
- Prior prosthetic heart valve in any position
- Any percutaneous coronary, carotid, or other endovascular intervention within 30 days prior to enrollment
- Any carotid surgery within 30 days prior to enrollment
- Any open cardiac or vascular surgery (other than carotid surgery) within 90 days prior to enrolment
- Myocardial infarction within 30 days prior to enrollment
- History of endocarditis within 6 months prior to enrollment or evidence of active systemic infection or sepsis
- Subject is on the waiting list for a transplant or has had a prior heart transplant
- Inability to tolerate anticoagulation or antiplatelet therapies
- Severe right ventricular dysfunction or severe tricuspid valve disease
- Cardiac resynchronization therapy (CRT) device implanted within 30 days of enrollment
- Active peptic ulcer or active GI bleeding within 90 days of enrollment
- Cardiogenic shock or hemodynamic instability requiring inotropic support or mechanical heart assistance
- Pulmonary arterial hypertension with fixed PASP > 70mmHg or PVR > 5WU that cannot be reduced to less than 5WU with vasodilator therapy
- Severe chronic obstructive pulmonary Disease (COPD) or airways disease requiring continuous home oxygen
- Known hypersensitivity or contraindication to procedural, post procedural medication (e.g., contrast solution) or hypersensitivity to nickel or titanium
- LVEF < 30%
- Renal insufficiency (eGFR <20 mL/min) or ESRD on dialysis
- Blood dycrasias as defined by acute anemia with Hb < 9, platelets < 75K, WBC < 0.5
- LVEDD > 70 mm
- Anatomic features (e.g., annular dimensions, neo-LVOT area, transfemoral and transseptal access, MAC) unsuitable for the Tioga TMVR System
- Severe aortic valve stenosis or regurgitation
- Evidence of intracardiac thrombus, vegetation, or mass
- Planned cardiovascular procedure within 30 days of enrolment
- Cerebrovascular accident (CVA) or transient ischemic attack (TIA) within 30 days of enrollment
- Life expectancy < 12 months
- Child class C cirrhosis
- Female subjects who is breast feeding or pregnant or planning to become pregnant within the study period
This trial is currently available in Brazil, Georgia, Lithuania, and Paraguay.
It has sites in 4 countries. Choose a country to see its sites.
About the trial
What the trial wants to find out
The study is aimed to assess the safety and feasibility of the Tioga TMVR System in treating patients with symptomatic MR (MR>=3+)
The group in the trial
- Patients with Symptomatic MR (MR>=3+)Treatment being tested
Subjects treated with the Tioga TMVR System
Treatment: Tioga TMVR System
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Evaluation of Safety and Feasibility of the Tioga TMVR System for Treatment of Mitral Regurgitation
- Record updated
- 12 November 2025